Reviva Pharmaceuticals Holdings (RVPH) Non Operating Interest Expenses (2023 - 2026)
Reviva Pharmaceuticals Holdings (RVPH) posted Non Operating Interest Expenses of $2,935 for Q2 2026, down 38.8% from $4,797 a year earlier and down 55.9% from the prior quarter.
Powered by 
Analysis
Reviva Pharmaceuticals Holdings (RVPH) Non Operating Interest Expenses (2023 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Non Operating Interest Expenses at Reviva Pharmaceuticals Holdings was $6,573, down 75.0% year-over-year; for FY2025, it was $13,402, down 27.5% from FY2024.
- Annual Non Operating Interest Expenses shows a five-year compound annual growth rate of -60.8% (FY2020 to FY2025).
- In prior years, Reviva Pharmaceuticals Holdings' Non Operating Interest Expenses was $18,497 in FY2024 (-45.2%) and $33,725 in FY2023.
- Quarterly Non Operating Interest Expenses has run from a low of -$5,620 in Q4 2025 to a high of $13,311 in Q4 2023 over five years.
- On a year-over-year basis, Non Operating Interest Expenses increased in 1 of the last seven quarters, with growth averaging 2.6%.
- The strongest year-over-year quarter for Non Operating Interest Expenses in the past five years was Q1 2025, with growth of 233.2%; the weakest was Q4 2024, with a decline of 64.6%.
- According to Business Quant data, Non Operating Interest Expenses for the three prior quarters was $6,653 (Q1 2026), -$5,620 (Q4 2025) and $2,605 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Reviva Pharmaceuticals Holdings | 6.16 Mn | 6.16 Mn | - | 2,935.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2,935.00 |
| Mar 31, 2026 | 6,653.00 |
| Dec 31, 2025 | -5,620.00 |
| Sep 30, 2025 | 2,605.00 |
| Jun 30, 2025 | 4,797.00 |
| Mar 31, 2025 | 11,620.00 |
| Dec 31, 2024 | 4,711.00 |
| Sep 30, 2024 | 5,146.00 |
| Jun 30, 2024 | 5,153.00 |
| Mar 31, 2024 | 3,487.00 |
| Dec 31, 2023 | 13,311.00 |
| Sep 30, 2023 | 5,901.00 |
| Jun 30, 2023 | 12,759.00 |
| Mar 31, 2023 | 7,655.00 |
API Access
Reviva Pharmaceuticals Holdings Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=RVPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "RVPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=RVPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();